Plasma Thrombin-Activatable Fibrinolytic Inhibitor (TAFI) among Healthy Subjects and Patients with Vascular Diseases: A Validation Study

Publisher： Karger

E-ISSN： 1424-8840|33|5-6|382-386

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.33, Iss.5-6, 2005-01, pp. : 382-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Selective modulation of thrombin‐activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin‐thrombomodulin complex using TAFI‐derived peptides

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 11, 2015-11 ,pp. : 2093-2101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 257-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 256-257

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 260-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of thrombin activatable fibrinolysis inhibitor (TAFI)

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 259-259

John Wiley & Sons Inc

Access to resources Recommend Favorite